In 'What's Ahead on Wall Street' for the week of Mar. 7, there are several companies reporting earnings, including burger chains and retailers. We kick off the week with Shake Shack (SHAK) and Urban Outfitters (URBN), followed by Dick's Sporting Goods (DKS) on Tuesday. Midweek, we'll hear from Vera Bradley (VRA) and Square (SQ) and on Thursday, we get results from Dollar General (DG), Vail Resorts (MTN) and Ulta Salon (ULTA). Out of these companies, all eyes will be on Square since this will be its first earnings report after going public in November. Based on the numbers, investors will get a good read on whether or not the company is off to a good start. For the recent quarter, Wall Street is look for a loss of $0.13 a share on revenue of $343.22 million. Recently, Pacific Crest said moving beyond processing and moving up market is crucial for Square to cement its unique model. Overall, analysts believe Square can take advantage of the rich ecosystem of transaction to achieve growth and gain customers. Additionally, we have some key reports on the economic calendar. Midweek, we have the weekly oil inventory data, followed by jobless claims and Treasury budget on Thursday. Finally, we end the week with import and export prices. TheStreet's U-Jin Lee reports from Wall Street.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.